Lorenzo Galluzzi
#56,686
Most Influential Person Now
Researcher
Lorenzo Galluzzi's AcademicInfluence.com Rankings
Lorenzo Galluzzibiology Degrees
Biology
#2296
World Rank
#3663
Historical Rank
Biotechnology
#20
World Rank
#20
Historical Rank
Cell Biology
#70
World Rank
#74
Historical Rank
Immunology
#126
World Rank
#133
Historical Rank
Download Badge
Biology
Lorenzo Galluzzi's Degrees
- PhD Biomedical Sciences Université Paris Cité
- Bachelors Biology University of Milan
Similar Degrees You Can Earn
Why Is Lorenzo Galluzzi Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lorenzo Galluzzi is an Italian and French cell biologist best known for his experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. Biography Galluzzi is currently assistant professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College and Assistant Professor Adjunct at the Department of Dermatology of the Yale University School of Medicine . Prior to joining Weill Cornell Medical College , Galluzzi was a Junior Scientist of the Research Team "Apoptosis, Cancer and Immunity" at the Cordeliers Research Center under the direction of Dr. Guido Kroemer. Galluzzi did his post-doctoral training at the Gustave Roussy Cancer Center , after receiving his PhD from the Paris Sud University . Galluzzi is associate director of the European Academy for Tumor Immunology , and Founding Member of the European Research Institute for Integrated Cellular Pathology .
Lorenzo Galluzzi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mitochondrial membrane permeabilization in cell death. (2007) (3372)
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (3106)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (2012) (2913)
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 (2005) (2802)
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 (2011) (2295)
- Immunogenic cell death in cancer therapy. (2013) (2210)
- Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes (2009) (2078)
- Molecular mechanisms of necroptosis: an ordered cellular explosion (2010) (2045)
- Molecular mechanisms of cisplatin resistance (2012) (1979)
- Immunogenic cell death in cancer and infectious disease (2016) (1609)
- Targeting mitochondria for cancer therapy (2010) (1422)
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice (2011) (1141)
- Regulation of autophagy by cytoplasmic p53 (2008) (1097)
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. (2015) (1062)
- Mechanisms of cytochrome c release from mitochondria (2006) (1036)
- Molecular definitions of autophagy and related processes (2017) (1036)
- Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging (2011) (985)
- Autophagy in malignant transformation and cancer progression (2015) (941)
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
- Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 (2014) (799)
- Acetyl coenzyme A: a central metabolite and second messenger. (2015) (791)
- Type I interferons in anticancer immunity (2015) (789)
- Cell death modalities: classification and pathophysiological implications (2007) (749)
- Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. (2013) (705)
- Mitotic catastrophe: a mechanism for avoiding genomic instability (2011) (696)
- Decoding cell death signals in liver inflammation. (2013) (692)
- Metabolic Control of Autophagy (2014) (678)
- Mitochondrial metabolism and cancer (2017) (675)
- Macrophages and Metabolism in the Tumor Microenvironment. (2019) (636)
- Consensus guidelines for the detection of immunogenic cell death (2014) (634)
- The secret ally: immunostimulation by anticancer drugs (2012) (626)
- Mitochondria: master regulators of danger signalling (2012) (616)
- Systems biology of cisplatin resistance: past, present and future (2014) (590)
- Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles (2017) (571)
- Inflammasomes in carcinogenesis and anticancer immune responses (2012) (538)
- Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. (2013) (534)
- Metabolic targets for cancer therapy (2013) (531)
- Metabolic control of cell death (2014) (521)
- Necroptosis: A Specialized Pathway of Programmed Necrosis (2008) (520)
- Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy (2010) (519)
- Cell death assays for drug discovery (2011) (510)
- Metabolic Control of Longevity (2016) (508)
- Autophagy regulation by p53. (2010) (472)
- Control of Metastasis by NK Cells. (2017) (452)
- Autophagy-Independent Functions of the Autophagy Machinery (2019) (448)
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) (423)
- Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome (2011) (421)
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors (2020) (412)
- Autophagy and Mitophagy in Cardiovascular Disease. (2017) (410)
- Mitochondrial Control of Cellular Life, Stress, and Death (2012) (407)
- Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition (2013) (406)
- Viral Control of Mitochondrial Apoptosis (2008) (397)
- Mitochondrial membrane permeabilization in neuronal injury (2009) (382)
- Necroptosis: Mechanisms and Relevance to Disease. (2017) (380)
- Anti- and pro-tumor functions of autophagy. (2009) (366)
- The hallmarks of successful anticancer immunotherapy (2018) (361)
- Classification of current anticancer immunotherapies (2014) (357)
- An Immunosurveillance Mechanism Controls Cancer Cell Ploidy (2012) (352)
- Autophagy and cellular immune responses. (2013) (350)
- Molecular mechanisms of ATP secretion during immunogenic cell death (2013) (341)
- Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death (2012) (339)
- Mitochondria as therapeutic targets for cancer chemotherapy (2006) (337)
- Cancer and the gut microbiota: An unexpected link (2015) (326)
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (323)
- The IKK complex contributes to the induction of autophagy (2010) (290)
- Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition (2014) (289)
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death (2015) (287)
- The spectrum of T cell metabolism in health and disease (2017) (282)
- Autophagy in major human diseases (2021) (282)
- The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1 (2009) (276)
- To die or not to die: that is the autophagic question. (2008) (275)
- miR-181a and miR-630 regulate cisplatin-induced cancer cell death. (2010) (269)
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy (2011) (267)
- Mutant p53 protein localized in the cytoplasm inhibits autophagy (2008) (265)
- Trial watch: IDO inhibitors in cancer therapy (2014) (260)
- Caspases Connect Cell-Death Signaling to Organismal Homeostasis. (2016) (257)
- Mitochondrial gateways to cancer. (2010) (252)
- No death without life: vital functions of apoptotic effectors (2008) (252)
- Combinatorial Strategies for the Induction of Immunogenic Cell Death (2015) (250)
- Natural and therapy-induced immunosurveillance in breast cancer (2015) (245)
- Linking cellular stress responses to systemic homeostasis (2018) (243)
- First oncolytic virus approved for melanoma immunotherapy (2016) (241)
- Detection of immunogenic cell death and its relevance for cancer therapy (2020) (238)
- Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy (2017) (233)
- Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. (2012) (232)
- Regulation of autophagy by stress-responsive transcription factors. (2013) (225)
- Trial Watch—Oncolytic viruses and cancer therapy (2016) (221)
- Methods for the assessment of mitochondrial membrane permeabilization in apoptosis (2007) (214)
- Molecular mechanisms of regulated necrosis. (2014) (213)
- Intratumoral heterogeneity in cancer progression and response to immunotherapy (2021) (210)
- Organelle-specific initiation of cell death (2014) (208)
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy (2015) (207)
- DNA Damage in Stem Cells. (2017) (207)
- The autophagic network and cancer (2018) (203)
- Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol (2009) (203)
- Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death (2008) (202)
- Methods for assessing autophagy and autophagic cell death. (2008) (194)
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy (2012) (179)
- Trial watch (2013) (176)
- Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics (2017) (173)
- Chloroquine and hydroxychloroquine for cancer therapy (2014) (169)
- Trial Watch: Monoclonal antibodies in cancer therapy (2012) (167)
- Organelle-Specific Initiation of Autophagy. (2015) (164)
- Senescence, Apoptosis or Autophagy? (2008) (164)
- Programmed necrosis from molecules to health and disease. (2011) (156)
- Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties. (2016) (155)
- Mitochondrial control of the NLRP3 inflammasome (2011) (153)
- Immunological impact of cell death signaling driven by radiation on the tumor microenvironment (2019) (152)
- Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. (2011) (149)
- Trial watch (2013) (148)
- Autophagy in acute brain injury (2016) (148)
- Cisplatin resistance associated with PARP hyperactivation. (2013) (146)
- Unsaturated fatty acids induce non‐canonical autophagy (2015) (146)
- Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy (2020) (143)
- Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C‐ring conformation (2017) (142)
- WNT Signaling in Cancer Immunosurveillance. (2019) (141)
- Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles (2018) (140)
- Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos (2010) (140)
- The life span-prolonging effect of Sirtuin-1 is mediated by autophagy (2010) (140)
- Cytosolic DNA Sensing in Organismal Tumor Control. (2018) (139)
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy (2018) (138)
- p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200 (2011) (135)
- Immunogenic cell stress and death (2022) (135)
- A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. (2007) (133)
- Illicit survival of cancer cells during polyploidization and depolyploidization (2011) (133)
- Pyroptosis – a cell death modality of its kind? (2010) (132)
- Crosstalk between ER stress and immunogenic cell death. (2013) (130)
- Guidelines and recommendations on yeast cell death nomenclature (2018) (129)
- Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. (2008) (127)
- A yeast BH3‐only protein mediates the mitochondrial pathway of apoptosis (2011) (125)
- Life, death and burial: multifaceted impact of autophagy. (2008) (125)
- Trial watch (2012) (124)
- Immunological Mechanisms Underneath the Efficacy of Cancer Therapy (2016) (123)
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology (2020) (123)
- Hormesis, cell death and aging (2011) (119)
- RIP kinases initiate programmed necrosis. (2009) (117)
- Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. (2007) (115)
- Prognostic impact of vitamin B6 metabolism in lung cancer. (2012) (114)
- Targeting post-mitochondrial effectors of apoptosis for neuroprotection. (2009) (114)
- Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer (2015) (113)
- CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. (2014) (113)
- Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications (2015) (111)
- Targeting p53 to mitochondria for cancer therapy (2008) (110)
- Trial watch (2012) (110)
- Tumor-Infiltrating Regulatory T Cells: Phenotype, Role, Mechanism of Expansion In Situ and Clinical Significance (2013) (109)
- Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. (2008) (108)
- Trial watch: Peptide-based vaccines in anticancer therapy (2018) (106)
- Non‐apoptotic functions of apoptosis‐regulatory proteins (2012) (106)
- Enlightening the impact of immunogenic cell death in photodynamic cancer therapy (2012) (105)
- Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set (2014) (104)
- Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy (2016) (103)
- Disruption of the hexokinase–VDAC complex for tumor therapy (2008) (102)
- Trial Watch: Peptide-based anticancer vaccines (2015) (102)
- Trial Watch (2013) (101)
- Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses (2013) (101)
- Immunogenic cell death in radiation therapy (2013) (100)
- Surface‐exposed calreticulin in the interaction between dying cells and phagocytes (2010) (100)
- Ca2+ Fluxes and Cancer. (2020) (100)
- Regulated cell death and adaptive stress responses (2016) (100)
- Erratum: Molecular mechanisms of cell death: Central implication of ATP synthase in mitochondrial permeability transition (Oncogene (2015) 34 (1475-1486 ) DOI: 10.1038/onc.2014.96) (2015) (100)
- Autophagy is required for the activation of NFκB (2012) (99)
- Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden (2018) (99)
- Inhibition of autophagy by TAB2 and TAB3 (2011) (99)
- Trial watch: STING agonists in cancer therapy (2020) (98)
- Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles (2019) (98)
- Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. (2019) (96)
- Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients (2018) (95)
- Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. (2016) (95)
- Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery (2009) (95)
- Autophagy-dependent ATP release from dying cells via lysosomal exocytosis (2013) (94)
- Trial watch: Dendritic cell-based anticancer immunotherapy (2017) (91)
- Characterization of novel MPS1 inhibitors with preclinical anticancer activity (2013) (91)
- Autophagy in hepatic adaptation to stress. (2020) (91)
- Trial watch: dendritic cell vaccination for cancer immunotherapy (2019) (90)
- Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death (2012) (89)
- Oncosuppressive functions of autophagy. (2011) (89)
- Mitochondrial apoptosis without VDAC (2007) (88)
- Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. (2011) (87)
- Metabolic targets for cancer therapy (2013) (87)
- Immunomodulation by targeted anticancer agents. (2020) (87)
- SnapShot: CGAS-STING Signaling (2018) (86)
- Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins (2012) (86)
- Trial Watch (2012) (86)
- TP53 and MTOR crosstalk to regulate cellular senescence (2010) (85)
- eIF2α phosphorylation as a biomarker of immunogenic cell death. (2015) (85)
- Functions of BCL-XL at the Interface between Cell Death and Metabolism (2013) (84)
- Trial Watch (2013) (83)
- Calreticulin and cancer (2020) (82)
- Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients (2019) (80)
- Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8 (2013) (80)
- Trial Watch (2012) (79)
- Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway (2007) (79)
- Mitochondrial control of cell death induced by hyperosmotic stress (2006) (79)
- Mitochondrial regulation of cell death: a phylogenetically conserved control (2016) (78)
- ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy (2013) (77)
- Trial watch (2013) (76)
- Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition (2015) (75)
- Mitochondrial liaisons of p53. (2011) (74)
- Trial Watch (2014) (72)
- Immunomodulation by anticancer cell cycle inhibitors (2020) (72)
- Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens (2012) (72)
- Oncogene-induced senescence and tumour control in complex biological systems (2018) (70)
- Trial watch: Dendritic cell-based anticancer therapy (2014) (70)
- Viral subversion of immunogenic cell death (2009) (67)
- Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy? (2015) (67)
- Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy (2012) (66)
- Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors (2019) (64)
- Akt‐mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth (2018) (64)
- MLKL regulates necrotic plasma membrane permeabilization (2014) (63)
- Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. (2021) (63)
- Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia (2012) (60)
- Immune recognition of irradiated cancer cells (2017) (60)
- Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome (2009) (60)
- Viral strategies for the evasion of immunogenic cell death (2010) (60)
- Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. (2019) (60)
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications (2016) (60)
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors (2018) (59)
- Trial watch: Immune checkpoint blockers for cancer therapy (2017) (59)
- Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. (2019) (57)
- Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop (2019) (57)
- Noncanonical Cell Fate Regulation by Bcl-2 Proteins. (2020) (56)
- Trial watch (2012) (56)
- PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models (2020) (56)
- ATP and cancer immunosurveillance (2021) (56)
- Trial Watch: Adoptively transferred cells for anticancer immunotherapy (2017) (55)
- Combinatorial Strategies for the Induction of Immunogenic Cell Death (2015) (55)
- TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer (2019) (54)
- Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy (2013) (53)
- Targeting HSP70 for cancer therapy. (2009) (53)
- Immunosurveillance as a regulator of tissue homeostasis. (2013) (53)
- Cell Death Signaling and Anticancer Therapy (2011) (52)
- Trial Watch (2012) (51)
- Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients (2019) (51)
- Past, Present, and Future of Molecular and Cellular Oncology (2011) (51)
- Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (2020) (51)
- Erlotinib antagonizes ABC transporters in acute myeloid leukemia (2012) (51)
- Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms. (2021) (51)
- Mitochondrial control of inflammation (2022) (50)
- Trial Watch: Radioimmunotherapy for oncological indications (2014) (50)
- Anticancer activity of cardiac glycosides (2012) (50)
- Autophagy in natural and therapy-driven anticancer immunosurveillance (2017) (49)
- Modeling Tumor Immunology and Immunotherapy in Mice. (2018) (49)
- Trial Watch: Lenalidomide-based immunochemotherapy (2013) (49)
- Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy (2016) (49)
- Selective killing of p53-deficient cancer cells by SP600125 (2012) (48)
- Trial watch: TLR3 agonists in cancer therapy (2020) (48)
- Changes in Mitochondrial Rna Production in Cells Treated with Nucleoside Analogues (2005) (48)
- Autophagy Mediates Tumor Suppression via Cellular Senescence. (2016) (47)
- IKK connects autophagy to major stress pathways (2010) (46)
- Trial watch (2005) (45)
- Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia (2013) (45)
- Victories and deceptions in tumor immunology (2013) (44)
- Trial Watch—Immunostimulation with cytokines in cancer therapy (2016) (44)
- Trial watch: Tumor-targeting monoclonal antibodies for oncological indications (2015) (44)
- Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors. (2018) (44)
- Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers. (2017) (43)
- Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients (2019) (43)
- Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer (2012) (42)
- p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis (2009) (42)
- Defective autophagy control by the p53 rheostat in cancer (2010) (42)
- Extracorporeal photochemotherapy induces bona fide immunogenic cell death (2019) (42)
- Trial Watch (2014) (41)
- EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells (2013) (41)
- An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe (2010) (40)
- Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression (2020) (40)
- Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia (2011) (40)
- Whole cell strategies based on lux genes for high throughput applications toward new antimicrobials. (2006) (39)
- Disruption of the PP1/GADD34 complex induces calreticulin exposure (2009) (39)
- M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer (2020) (39)
- Trial Watch: experimental TLR7/TLR8 agonists for oncological indications (2020) (39)
- Ferroptosis in p53-dependent oncosuppression and organismal homeostasis (2015) (38)
- Trial Watch (2014) (37)
- Impact of myeloid cells on the efficacy of anticancer chemotherapy. (2014) (37)
- Trial Watch (2012) (37)
- Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing (2016) (36)
- Antiapoptotic activity of argon and xenon (2013) (36)
- Fighting Resilient Cancers with Iron. (2017) (36)
- Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy (2018) (36)
- Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia (2011) (35)
- Immunosurveillance against tetraploidization-induced colon tumorigenesis (2013) (35)
- Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells (2008) (35)
- Longevity-relevant regulation of autophagy at the level of the acetylproteome (2011) (35)
- Preferential killing of p53-deficient cancer cells by reversine (2012) (35)
- Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison. (2008) (35)
- Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy (2014) (35)
- Novel immune checkpoint blocker approved for the treatment of advanced melanoma (2014) (34)
- Mechanisms of p53-mediated mitochondrial membrane permeabilization (2008) (34)
- Trial watch: dietary interventions for cancer therapy (2019) (33)
- Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 (2016) (33)
- Direct molecular interactions between Beclin 1 and the canonical NFκB activation pathway (2012) (32)
- Methods to dissect mitochondrial membrane permeabilization in the course of apoptosis. (2008) (32)
- Trial Watch: Adoptive cell transfer for oncological indications (2015) (32)
- Intracellular redox equilibrium and growth phase affect the performance of luciferase-based biosensors. (2007) (32)
- Trial Watch (2013) (31)
- Exogenous and Endogenous Sources of Serine Contribute to Colon Cancer Metabolism, Growth, and Resistance to 5-Fluorouracil (2021) (31)
- Apaf-1 Deficiency Causes Chromosomal Instability (2007) (31)
- A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint (2009) (31)
- Autophagy and innate immunity ally against bacterial invasion (2011) (31)
- Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) (31)
- Secondary Necrosis: Accidental No More. (2017) (30)
- Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications (2017) (30)
- Current trends of anticancer immunochemotherapy (2013) (30)
- Altered Mitochondrial Rna Production in Adipocytes from HIV-Infected Individuals with Lipodystrophy (2005) (30)
- MITOCHONDRIAL PERMEABILIZATION IN CELL DEATH (2007) (30)
- Independent transcriptional reprogramming and apoptosis induction by cisplatin (2012) (29)
- Trial watch (2013) (29)
- Trial watch: Naked and vectored DNA-based anticancer vaccines (2015) (29)
- Trial Watch (2014) (29)
- Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo (2015) (28)
- Autophagy in the cancer-immunity dialogue. (2020) (28)
- Trial watch (2005) (28)
- Karyotypic Aberrations in Oncogenesis and Cancer Therapy. (2015) (27)
- Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma—An exclamation sign with a question mark (2015) (27)
- Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer (2021) (27)
- Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients (2019) (27)
- Vitamin B6 metabolism influences the intracellular accumulation of cisplatin (2013) (27)
- Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate. (2019) (26)
- Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy (2013) (26)
- Shigella targets the mitochondrial checkpoint of programmed necrosis. (2009) (26)
- Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer (2021) (25)
- Trial watch: IDO inhibitors in cancer therapy (2020) (25)
- An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells (2013) (24)
- Trial Watch (2004) (24)
- Trial watch: DNA-based vaccines for oncological indications (2017) (24)
- Trial watch (2006) (24)
- Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment (2022) (23)
- Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade (2020) (22)
- Stress responses in stromal cells and tumor homeostasis. (2019) (21)
- Trial Watch: Proteasomal inhibitors for anticancer therapy (2014) (21)
- Involvement of autophagy in NK cell development and function (2017) (21)
- Apoptotic caspases cut down the immunogenicity of radiation (2019) (20)
- Mitochondrial Dynamics: A Strategy for Avoiding Autophagy (2011) (20)
- High-Throughput Quantification of GFP-LC3+ Dots by Automated Fluorescence Microscopy. (2017) (19)
- Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade (2017) (19)
- Trial Watch (2013) (19)
- Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression (2020) (18)
- TREX1 Cuts Down on Cancer Immunogenicity. (2017) (18)
- Defective Autophagy Initiates Malignant Transformation. (2016) (18)
- Immunological configuration of ovarian carcinoma: features and impact on disease outcome (2021) (18)
- Trial watch (2006) (18)
- Novel insights into the mitochondrial permeability transition (2014) (18)
- Mitochondrial control of innate immune signaling by irradiated cancer cells (2020) (17)
- Prognostic value of LIPC in non-small cell lung carcinoma (2013) (17)
- Reverse Warburg: Straight to cancer (2012) (17)
- Trial watch (2005) (17)
- Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery. (2021) (16)
- Mitochondrial control of cell death induced by hyperosmotic stress (2006) (16)
- Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. (2021) (16)
- Bacterial Invasion: Linking Autophagy and Innate Immunity (2010) (16)
- Immunological effects of chemotherapy in spontaneous breast cancers (2013) (16)
- Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Death” (2015) (15)
- Drugging cancer metabolism: Expectations vs. reality. (2019) (15)
- Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing (2019) (15)
- BAX and BAK at the Gates of Innate Immunity. (2018) (15)
- Vitamin B6 improves the immunogenicity of cisplatin-induced cell death (2014) (15)
- Calreticulin arms NK cells against leukemia (2019) (15)
- Necroptosis turns TNF lethal. (2011) (15)
- Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids (2015) (15)
- NF-κB blockade upregulates Bax, TSP-1, and TSP-2 expression in rat granulation tissue (2009) (15)
- New immunotherapeutic paradigms for castration-resistant prostate cancer (2013) (14)
- Reply: Immunosuppressive cell death in cancer (2017) (14)
- Conceptual background and bioenergetic/mitochondrial aspects of oncometabolism (2014) (14)
- A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients. (2021) (14)
- Novel insights into the mechanism of action of lenalidomide (2014) (14)
- PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab (2018) (13)
- Immunogenic Cell Death and Cancer (2021) (13)
- Trial watch: intratumoral immunotherapy (2021) (13)
- LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells (2021) (13)
- Cancer Immunotherapy Principles and Practice (2018) (13)
- Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors (2016) (13)
- Inhibition of autophagy by TAB 2 and TAB 3 (2011) (13)
- Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. (2019) (13)
- Trial watch (2013) (12)
- Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cells. (2010) (12)
- Metabolic enzymes expressed by cancer cells impact the immune infiltrate (2019) (12)
- Lysosome-targeting agents in cancer therapy (2017) (12)
- FADD: an endogenous inhibitor of RIP3-driven regulated necrosis (2011) (12)
- Evaluation of rapamycin-induced cell death. (2012) (12)
- Unexpected role of the phosphate carrier in mitochondrial fragmentation (2008) (12)
- STAT3 inhibition for cancer therapy: Cell-autonomous effects only? (2016) (12)
- Cell Senescence (2013) (12)
- Amplified Detection of Transcriptional and Translational Inhibitors in Bioluminescent Escherichia Coli K-12 (2003) (11)
- Fluorescent biosensors for the detection of HMGB1 release. (2013) (11)
- TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients (2021) (11)
- Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate (2018) (11)
- Trial Watch (2012) (11)
- Immunosurveillance against cancer-associated hyperploidy (2012) (11)
- Cancer immunotherapy turns viral (2013) (11)
- Novel multifunctional antibody approved for the treatment of breast cancer (2013) (10)
- Trial Watch (2013) (10)
- A new role for cytoplasmic p53: Binding and destroying double-stranded RNA (2010) (10)
- Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma (2015) (10)
- Immune effectors required for the therapeutic activity of vorinostat (2013) (10)
- Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents (2021) (10)
- Doubling the blockade for melanoma immunotherapy (2016) (9)
- PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes (2022) (9)
- Cytofluorometric assessment of cell cycle progression. (2013) (9)
- A real-time analysis of QacR-regulated multidrug resistance in Staphylococcus aureus. (2003) (9)
- Control of host mitochondria by bacterial pathogens. (2021) (9)
- Nutlin kills cancer cells via mitochondrial p53 (2009) (9)
- Novel function of cytoplasmic p53 at the interface between mitochondria and the endoplasmic reticulum (2015) (9)
- Meta-hallmarks of aging and cancer. (2023) (9)
- Trial Watch (2004) (9)
- Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial. (2021) (9)
- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. (2022) (8)
- Immunogenicity of cell death driven by immune effectors (2020) (8)
- Heavy Metal to Rock the Immune Infiltrate. (2017) (8)
- Calreticulin and type I interferon: An unsuspected connection (2017) (8)
- Cancer Cells Thrive on Stress. (2019) (8)
- Common and divergent functions of Beclin 1 and Beclin 2 (2013) (8)
- Possible mechanisms of cancer prevention by nicotinamide (2020) (8)
- Trial Watch: (2013) (7)
- 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors. (2012) (7)
- An autologous dendritic cell vaccine promotes anticancer immunity in ovarian cancer patients with low mutational burden and cold tumors. (2022) (7)
- Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment. (2020) (7)
- CARs on a highway with roadblocks (2017) (7)
- Cytofluorometric purification of diploid and tetraploid cancer cells. (2011) (7)
- Necrosis: Linking the Inflammasome to Inflammation. (2015) (7)
- Immunosuppressive γδ T cells foster pancreatic carcinogenesis (2016) (7)
- Myeloid-Derived Suppressor Cells and Radiotherapy. (2022) (7)
- Trial watch (2004) (7)
- NK cells beat T cells at early breast cancer control (2020) (7)
- BAX and BAK dynamics control mitochondrial DNA release during apoptosis (2022) (6)
- Immunological control of cell cycle aberrations for the avoidance of oncogenesis: the case of tetraploidy (2013) (6)
- Immunology of Cell Death in Cancer Immunotherapy (2021) (6)
- NK cells and solid tumors: therapeutic potential and persisting obstacles (2022) (6)
- Pathophysiology of Cancer Cell Death (2020) (6)
- Involvement of p38α in the mitotic progression of p53-/- tetraploid cells (2010) (6)
- Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop (2019) (5)
- Nucleic Acid Sensing at the Interface Between Innate and Adaptive Immunity. (2019) (5)
- Trial Watch (2012) (5)
- Novel Insights into PML-Dependent Oncosuppression. (2016) (5)
- Using epigenetic modifiers to target cancer stem cell immunoevasion. (2021) (5)
- Mitophagy: Permitted by Prohibitin (2017) (5)
- Driving to Cancer on a Four-Lane Expressway. (2017) (5)
- Reply: The complement system is also important in immunogenic cell death (2016) (5)
- Assessment of Glycolytic Flux and Mitochondrial Respiration in the Course of Autophagic Responses. (2017) (5)
- Methods to Detect Immunogenic Cell Death In Vivo. (2020) (5)
- PD-L1 blockade for urothelial carcinoma (2017) (5)
- Aberrant ketolysis fuels hepatocellular cancer progression (2016) (5)
- Algorithmic prediction of response to checkpoint inhibitors: Hyperprogressors versus responders. (2017) (4)
- Transgenerational cell fate profiling (2013) (4)
- Prevention of breast cancer by RANKL/RANK blockade (2016) (4)
- Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors? (2020) (4)
- Autophagy mediates the metabolic benefits of endurance training. (2012) (4)
- Novel inducers of BECN 1-independent autophagy : cis-unsaturated fatty acids (2015) (4)
- Detection of Apoptotic Versus Autophagic Cell Death by Flow Cytometry. (2016) (4)
- Molecular Regulation of Circadian Rhythms by Polyamines. (2015) (4)
- T Cells: Friends and Foes. (2019) (4)
- Preface: oncometabolism: a new field of research with profound therapeutic implications. (2014) (4)
- Rejuvenated T cells attack old tumors (2013) (4)
- Molecular and Cellular Oncology (2014) (3)
- Targeting Mutant KRAS for Immunogenic Cell Death Induction. (2019) (3)
- Autophagie, bonne santé et longévité (2017) (3)
- Etiological involvement of CFTR in apparently unrelated human diseases (2019) (3)
- Cell-wide metabolic alterations associated with malignancy (2014) (3)
- Blinatumomab bridges the gap between leukemia and immunity (2017) (3)
- CD103+ cells at the forefront of anticancer immunity (2017) (3)
- A four-lane highway to cancer (2016) (3)
- MDSCs sneak CSCs out of (immuno)surveillance (2021) (3)
- Preface: Endoplasmic reticulum in health and disease. (2020) (3)
- Amino acid deprivation promotes intestinal homeostasis through autophagy (2016) (2)
- [Autophagy, fitness and longevity]. (2017) (2)
- Immuno-epigenetic escape of cancer stem cells (2022) (2)
- Chromatin and genomic instability in cancer. (2021) (2)
- The inflamed phenotype in PD-L1 negative melanoma and response to checkpoint inhibitors. (2017) (2)
- Abstract B199: Potent induction of immunogenic cell death by PT-112 (2019) (2)
- Preface: Dendritic cells: Master regulators of innate and adaptive immunity. (2019) (2)
- Senescence Inflames the Pancreatic Tumor Microenvironment (2020) (2)
- Laurie Menger Cell Death Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic (2012) (2)
- An epigenetic modifier triggers therapeutic immune responses against breast cancer (2017) (2)
- Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells (2021) (2)
- Discarding multidrug resistance inducers, the possible role of a biosensing reporter in antimicrobial discovery. (2004) (2)
- Boosting CAR T Cell Expansion and Therapeutic Activity with Low-dose Radiation Therapy (2020) (2)
- Born to Kill: NK Cells Go to War against Cancer. (2019) (2)
- Heterogeneous cellular effects of α-ketoglutarate esters (2019) (2)
- P03.24 Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients (2020) (2)
- Immunostimulatory effects of radioimmunotherapy (2022) (2)
- Defective autophagy gets to the brain (2015) (2)
- Immunological barriers to immunotherapy in primary and metastatic breast cancer (2021) (2)
- Everybody In! No Bouncers at Tumor Gates. (2017) (2)
- Preface-Autophagy: An old mechanism with new challenges ahead. (2020) (2)
- Integrated Systems and Technologies Cancer Research miR-181 a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death (2010) (2)
- Erratum to Morselli E, et al. Cell Cycle 2008; 7:3056–61 (2014) (1)
- Could Protons Promote Tumor Control by Avoiding Lymphopenia? (2021) (1)
- Canonical versus noncanonical autophagy (2021) (1)
- Targeting replication stress to tackle cancer stem cells (2021) (1)
- A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients (2022) (1)
- Novel immune checkpoint blocker to treat Merkel cell carcinoma (2017) (1)
- Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (2020) (1)
- Restored Ketosis Drives Anticancer Immunity in Colorectal Cancer. (2022) (1)
- Trial watch (2004) (1)
- Cytofluorometric Quantification of Cell Death Elicited by NLR Proteins. (2016) (1)
- 733 Potent immunogenic cell death (ICD) caused by UVA-Activated 8-Methoxypsoralen (8-MOPA) (2019) (1)
- The Capacity of the Hypomethylating Agents Azacytidine and Decitabine to Induce Apoptosis and Cell Cycle Arrest Depends on the Activation of the DNA-Damage Response Pathway. (2008) (1)
- Ketosis versus carbotoxicity – metabolism determines the outcome of cancer immunotherapy (2021) (1)
- ADP-Ribosylation Factor-Like 8B (2012) (1)
- Increased Proliferation Induced by Constitutive Activation of the Src-Kinase Lyn and Aberrant mTOR Signaling in AML Is Abrogated by the EGFR-Inhibitor Erlotinib. (2009) (1)
- Radiation unlocks the therapeutic potential of immune checkpoint blockers in lung cancer patients (2019) (1)
- Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles (2019) (1)
- Viperin turns coat in cytomegalovirus infection. (2011) (1)
- Mitochondria in Cell Death Regulation (2016) (1)
- Developing antisense oligonucleotides for a TECPR2 mutation-induced, ultra-rare neurological disorder using patient-derived cellular models (2022) (1)
- Microenvironment and Immunology CCL 2 / CCR 2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy (2014) (1)
- MPA/DMBA-driven mammary carcinomas. (2021) (1)
- Targeting Serine in Cancer: Is Two Better Than One? (2021) (1)
- Cancer Immunotherapy with CDK7 Inhibitors. (2020) (1)
- Preface: More than two decades of modern tumor immunology. (2020) (1)
- Adaptation to MOMP drives cancer persistence (2022) (1)
- Anticancer effects of PARP1 hyperactivation by a decoy oligodeoxynucleotide in vitro and in vivo. (2022) (1)
- BAX and BAK dynamics control mitochondrial DNA release during apoptosis (2022) (1)
- Abstract OT1-01-02: A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-Breast (2018) (1)
- Preface: More than two decades of modern tumor immunology. (2019) (1)
- "TripleC" : une étude de biologie des systèmes sur l'apoptose (2008) (0)
- P039 The EGFR-inhibitor erlotinib exhibits various off-target effects in MDS and AML (2007) (0)
- Regulated cell death and adaptive stress responses (2016) (0)
- Death Membrane Permeabilization in Cell (2007) (0)
- Author Correction: Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer (2022) (0)
- Abstract 1812: ROS-dependent activation of immunogenic glioblastoma cell death & release of immunogenic particles by an autologous cell-based immunotherapeutic platform (2023) (0)
- Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia (2023) (0)
- Radiation therapy: An old dog learning new tricks. (2022) (0)
- Abstract PO-036: Immunological characterization of mouse HR+ mammary tumors relapsing after radiation therapy (2021) (0)
- Low-Dose Radiation Improves Anti-CD19 CAR T-Cells Efficacy in Diffuse Large B-Cell Lymphoma through Fas/FasL Pathway (2022) (0)
- Abstract B76: Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients (2020) (0)
- ErratumNonapoptotic Role for Apaf-1 in the DNA Damage Checkpoint (2012) (0)
- Maturation and activation of T cells (2021) (0)
- Abstract A24: Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients (2020) (0)
- Abstract 6200: PARP1 hyperactivation by the decoy oligodeoxynucleotide OX425 mediates DNA repair abrogation and unleashes the anti-tumor immune response (2023) (0)
- Abstract 3745: Exogenous and endogenous sources of serine contribute to colon cancer metabolism and growth (2020) (0)
- Abstract 3115: PARP overactivation predicts the susceptibility of human cancer cells to apoptosis induction by PARP inhibitors (2012) (0)
- Emergent impact of lifestyle on tumor progression and response to therapy. (2022) (0)
- 733 Immunological mechanisms of resistance to CDK4/CDK6 inhibitors in breast cancer (2021) (0)
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients (2023) (0)
- Immunological impact of cell death signaling driven by radiation on the tumor microenvironment (2019) (0)
- SP-0130 Apoptotic caspases - Key regulators of the interaction between radiotherapy and anticancer immunity (2021) (0)
- Immunomodulation by anticancer cell cycle inhibitors (2020) (0)
- Erratum to: Mitochondrial control of cell death induced by hyperosmotic stress (2013) (0)
- Abstract B96: Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients (2020) (0)
- Abstract 4840: Radiation therapy as a tool to sensitize HR+breast cancer and mantle cell lymphoma to CDK4/6 inhibitors (2020) (0)
- Preface: Life through death-Key role of cellular suicide for colonial and organismal homeostasis. (2020) (0)
- Immunogenic cell death in cancer: concept and therapeutic implications (2023) (0)
- Preface: Ca2+ in health and disease. (2021) (0)
- An immunosurveillance mechanism controls cancer cell ploidy. Supplementary Material. (2013) (0)
- T cell-independent abscopal responses to radiotherapy. (2022) (0)
- 1118 Immunologically relevant effects of PT-112 on cancer cell mitochondria (2022) (0)
- Quantitative assessment of mitophagy in irradiated cancer cells. (2023) (0)
- Tumor Immunology and Immunotherapy – Molecular Methods (2019) (0)
- Preface - Extracellular vesicles: An exciting and rapidly expanding field of investigation. (2020) (0)
- Synergistic Effect of Hypofractionated Radiation and PD-1 Blockage in an Endogenous Model of HR+ Breast Cancer (2019) (0)
- Myeloid-derived suppressor cells: Emerging players in cancer and beyond. (2023) (0)
- How Cancer Cells Die And Why It Matters (2018) (0)
- RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. (2022) (0)
- 1144 IL17-producing γδ T cells promote resistance to CDK4/6 inhibitors in HR+HER2-breast cancer (2022) (0)
- Epigenetic escape of immunosurveillance by malignant cell precursors. (2023) (0)
- Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy. (2021) (0)
- Erratum to Criollo A, et al. Cell Cycle Volume 11, Issue 1; pp. 194-9 (2012) (0)
- 1126 Molecular mechanisms of DC activation by melanoma cells responding to LTX-315 (2022) (0)
- Abstract A150: Enhancing abscopal responses to radiation therapy by manipulating autophagy (2019) (0)
- Preface: Life through death-Key role of cellular suicide for colonial and organismal homeostasis. (2020) (0)
- Abstract 4691: Overactivation of poly (ADP-ribose) polymerase (PARP) in localised non-small cell lung cancer (NSCLC) predicts dismal prognosis (2014) (0)
- Immune Effects of Conventional Cancer Therapeutics (2021) (0)
- Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives. (2021) (0)
- 1114 Immunotherapeutic activity of OX425 against PD-1 resistant HR+HER2-breast cancer (2022) (0)
- Trial Watch (2013) (0)
- Trial Watch (2012) (0)
- Preface: More than two decades of modern tumor immunology. (2020) (0)
- Monitoring abscopal responses to radiation in mice. (2020) (0)
- Apoptotic cell death in disease—Current understanding of the NCCD 2023 (2023) (0)
- T-Cell Clonal Expansion and Activation Associated with Durable Clinical Response to Dual BTK and CDK4/6 Inhibitor Therapy in Mantle Cell Lymphoma (2019) (0)
- Preface: oncometabolism: a new field of research with profound therapeutic implications. (2014) (0)
- Cytofluorometric assessment of cell cycle progression in irradiated cells. (2022) (0)
- 618 POSTER A novel tyrosine kinase inhibitor exhibits significant anti-proliferative/pro-apoptotic effects in non-small cell lung cancer models (2006) (0)
- Composite Copy Number Variation in CDK4, CDKN2A and RB1 Predisposes Mantle Cell Lymphoma to Expansion of PD1+ Tumor Cells and Resistance to CDK4/6 Inhibitor Therapy as Revealed by Integrative Longitudinal scRNA-seq (2019) (0)
- Verification of a sonar localisation by means of a mathematical model of an anomalous multi-media detection system (1985) (0)
- 18P PARP1 trapping and hyperactivation by the decoy agonist OX425 induces DNA repair abrogation and a robust anti-tumor immune response (2023) (0)
- TICB 1283 No . of Pages 2 Spotlight Novel Insights into PML-Dependent (2016) (0)
- Diffuse Large B Cell Pdtx in Humanized Mice Are Valuable Models to Study Host-Lymphoma Interactions and Immune-Modulating Agents (2021) (0)
- Adenylyl Cyclase Inhibitory Gi Alpha Subunit (2012) (0)
- New Evidence on the Pathological Role of Permeability Transition Pore in Patients with STEMI (2020) (0)
- Oncosuppressive functions of PIDD1 in response to centrosome amplification (2021) (0)
- Calreticulin surface presentation can promote quality control of hematopoietic stem cells. (2022) (0)
- Preface-Dendritic cells: Master regulators of innate and adaptive immunity. (2019) (0)
- Quantification of cell cycle-arresting proteins. (2013) (0)
- Simulating cancer: computational models in oncology (2013) (0)
- Selective Suppression of the DNA Damage Response in Acute Myeloid Leukemia Versus Myelodysplastic Syndrome. (2008) (0)
- Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors (2023) (0)
- 285 Breaking through the resistance of breast cancer to immune checkpoint blockers in a unique mouse model of HR+ disease (2021) (0)
- Preface: More than two decades of modern tumor immunology. (2020) (0)
- Physiological Roles of the Permeability Transition Pore (2012) (0)
- Today's Special on the Anticancer Menu: Immunomodulation by Antifolates (2019) (0)
- Abstract 706: Novel MPS1 inhibitors with potential anticancer activity. (2013) (0)
- Ankyrine-Rich TRP Channel, ANKTM1, TRPA1 (2012) (0)
- Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis. (2022) (0)
- Ca2+ in health and disease. (2021) (0)
- Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives. (2022) (0)
- preclinical study Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a (2008) (0)
- The DNA Damage Response and Inflammation in Cancer. (2023) (0)
- Mitochondria analysis for investigating toxicity of antiretroviral drugs. (2004) (0)
- The Grand Challenges to Cellular and Molecular Oncology (2011) (0)
- Positive and Negative Impact of Immune Cells on Disease Outcome in Cancer Patients Treated with Chemotherapy Cells Markers Cancer Type (2015) (0)
- Oncogene-induced senescence and tumour control in complex biological systems (2018) (0)
- Preface: Chemical carcinogenesis in mice as a model of human cancer: Pros and cons. (2021) (0)
- The inflamed phenotype in PD-L1 negative non-small cell lung cancer (NSCLC) and response to checkpoint inhibitors (2017) (0)
- Preface: More than two decades of modern tumor immunology. (2020) (0)
- Further Evidence That MDS and AML Cells Exhibit a Differential Capacity To Activate the DNA-Damage Response (DDR) Pathways. (2007) (0)
- Molecular and Cellular Oncology (2014) (0)
- 560 Immunotherapeutic and antimetastatic activity of LTX-315 in preclinical models of ICI-resistant breast cancer (2021) (0)
- Caspase 2 and p53 Reunited in Tumor Control. (2020) (0)
- Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy (2020) (0)
- Nucleic Acid Sensing at the Interface Between Innate and Adaptive Immunity. (2019) (0)
- Linking cellular stress responses to systemic homeostasis (2018) (0)
- Platinum-based chemotherapy inflames the ovarian carcinoma microenvironment through cellular senescence (2022) (0)
- The autophagic network and cancer (2018) (0)
- Preface: Life through death-Key role of cellular suicide for colonial and organismal homeostasis. (2020) (0)
- Catastrophic DNA replication in unscheduled tetraploid cells. (2022) (0)
- The EGFR-Inhibitor Erlotinib Induces Differentiation, Cell Cycle Arrest and Apoptosis in EGFR-Negative Cells of MDS and AML. (2007) (0)
- Nucleic acid sensing and immunity (2019) (0)
- T Cells: Friends and Foes. (2018) (0)
- Vesicular trafficking in cellular responses to stress. (2021) (0)
- Metabolomic profiling of cultured cancer cells. (2014) (0)
- Radiation therapy: An old dog learning new tricks. (2023) (0)
- Vesicular trafficking in cellular responses to stress. (2021) (0)
- Evidence of Abundant Purifying Selection in Humans for Recently Acquired Regulatory Functions (2012) (0)
- 1071 Autologous tumor cell immunotherapeutic platform induces stress-correlated immunogenic cell death leading to immune activation within the draining lymph nodes (2022) (0)
- 446 HR+breast cancer: Defining innate and acquired resistance to immune checkpoint inhibitors (2022) (0)
- p53 regulates the mitochondrial immune checkpoint. (2023) (0)
- Cytofluorometric assessment of acute cell death responses driven by radiation therapy. (2022) (0)
- Beth Levine in memoriam (2020) (0)
- Calreticulin and cancer (2020) (0)
- Correction to: Methods to Detect Immunogenic Cell Death In Vivo. (2020) (0)
- Exercising Mitochondria for Cardioprotection Mitochondria and Endothelial Function Mitochondria and ROS Generation (2012) (0)
- Abca (1981) (0)
This paper list is powered by the following services:
Other Resources About Lorenzo Galluzzi
What Schools Are Affiliated With Lorenzo Galluzzi?
Lorenzo Galluzzi is affiliated with the following schools:
